Uto, Hirofumi

Publishing since 2000 (Senior)

Has published 39 publications in 11 years

Number of publications published per year by Uto, Hirofumi. (Source : PubMed)

Distribution of publications types for Uto, Hirofumi. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Takami Y, Uto H, Tamai T, Sato Y, Ishida YI, Morinaga H, Sakakibara Y, Moriuchi A, Oketani M, Ido A, Nakajima T, Okanoue T, Tsubouchi H. Identification of a novel biomarker for oxidative stress induced by hydrogen peroxide in primary human hepatocytes using the 2-nitrobenzenesulfenyl chloride isotope labeling method.  Hepatol. Res.  2010  
•  Nishida C, Uto H, Oketani M, Tokunaga K, Nosaki T, Fukumoto M, Oku M, Sogabe A, Moriuchi A, Ido A, Tsubouchi H. Clinical significance of alanine aminotransferase levels and the effect of ursodeoxycholic acid in hemodialysis patients with chronic hepatitis C.  J. Gastroenterol.  2010;45;3  
•  Takami Y, Uto H, Takeshita M, Kai H, Akamatsu E, Moriuchi A, Hasegawa S, Oketani M, Ido A, Kataoka H, Tsubouchi H. Proanthocyanidin derived from the leaves of Vaccinium virgatum suppresses platelet-derived growth factor-induced proliferation of the human hepatic stellate cell line LI90.  Hepatol. Res.  2010  
•  Kanmura S, Uto H, Sato Y, Kumagai K, Sasaki F, Moriuchi A, Oketani M, Ido A, Nagata K, Hayashi K, Stuver SO, Tsubouchi H. The complement component C3a fragment is a potential biomarker for hepatitis C virus-related hepatocellular carcinoma.  J. Gastroenterol.  2009  
•  Uto H. alpha-Glucosidase inhibitor acarbose and sequestome 1/A170/p62 deficient mice: A promising therapy and unique model for non-alcoholic fatty liver disease.  Hepatol. Res.  2009;39;9  
•  Uto H, Stuver SO, Hayashi K, Kumagai K, Sasaki F, Kanmura S, Numata M, Moriuchi A, Hasegawa S, Oketani M, Ido A, Kusumoto K, Hasuike S, Nagata K, Kohara M, Tsubouchi H. Increased rate of death related to presence of viremia among hepatitis C virus antibody-positive subjects in a community-based cohort study.  Hepatology  2009;50;2  
•  Kanmura S, Uto H, Numata M, Hashimoto S, Moriuchi A, Fujita H, Oketani M, Ido A, Kodama M, Ohi H, Tsubouchi H. Human neutrophil peptides 1-3 are useful biomarkers in patients with active ulcerative colitis.  Inflamm. Bowel Dis.  2009;15;6  
•  Takahama Y, Uto H, Kanmura S, Oketani M, Ido A, Kusumoto K, Hasuike S, Nagata K, Hayashi K, Stuver S, Okayama A, Tsubouchi H. Association of a genetic polymorphism in ectonucleotide pyrophosphatase/phosphodiesterase 1 with hepatitis C virus infection and hepatitis C virus core antigen levels in subjects in a hyperendemic area of Japan.  J. Gastroenterol.  2008;43;12  
•  Kodama M, Uto H, Numata M, Hori T, Murayama T, Sasaki F, Tsubouchi N, Ido A, Shimoda K, Tsubouchi H. Endoscopic characterization of the small bowel in patients with portal hypertension evaluated by double balloon endoscopy.  J. Gastroenterol.  2008;43;8  
•  Imamura Y, Uto H, Oketani M, Hiramine Y, Hosoyamada K, Sho Y, Hiwaki T, Baba Y, Tahara K, Kubozono O, Kusano K, Tsubouchi H. Association between changes in body composition and the increasing prevalence of fatty liver in Japanese men.  Hepatol. Res.  2008;38;11  

[ See timeline ] [ See all publications ]